-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Eagle Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2012 to 2022.
- Eagle Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$33.5M, a 102% decline year-over-year.
- Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $50.7M, a 79.7% increase from 2021.
- Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $28.2M, a 43% decline from 2020.
- Eagle Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was $49.5M, a 11.6% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)